118 related articles for article (PubMed ID: 36624125)
1. Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Sci Rep; 2023 Jan; 13(1):444. PubMed ID: 36624125
[TBL] [Abstract][Full Text] [Related]
2. Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.
Kraft T; Grützmann K; Meinhardt M; Meier F; Westphal D; Seifert M
Acta Neuropathol Commun; 2024 Apr; 12(1):67. PubMed ID: 38671536
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.
Chen G; Chakravarti N; Aardalen K; Lazar AJ; Tetzlaff MT; Wubbenhorst B; Kim SB; Kopetz S; Ledoux AA; Gopal YN; Pereira CG; Deng W; Lee JS; Nathanson KL; Aldape KD; Prieto VG; Stuart D; Davies MA
Clin Cancer Res; 2014 Nov; 20(21):5537-46. PubMed ID: 24803579
[TBL] [Abstract][Full Text] [Related]
4. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases.
Westphal D; Meinhardt M; Grützmann K; Schöne L; Steininger J; Neuhaus LT; Wiegel M; Schrimpf D; Aust DE; Schröck E; Baretton GB; Beissert S; Juratli TA; Schackert GG; Gravemeyer J; Becker JC; von Deimling A; Koelsche C; Klink B; Meier F; Schulz A; Muders MH; Seifert M
J Invest Dermatol; 2023 Jul; 143(7):1233-1245.e17. PubMed ID: 36716920
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
Harding JJ; Catalanotti F; Munhoz RR; Cheng DT; Yaqubie A; Kelly N; McDermott GC; Kersellius R; Merghoub T; Lacouture ME; Carvajal RD; Panageas KS; Berger MF; Rosen N; Solit DB; Chapman PB
Oncologist; 2015 Jul; 20(7):789-97. PubMed ID: 25956405
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
[TBL] [Abstract][Full Text] [Related]
7. Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups.
Grützmann K; Kraft T; Meinhardt M; Meier F; Westphal D; Seifert M
Comput Struct Biotechnol J; 2024 Dec; 23():1036-1050. PubMed ID: 38464935
[TBL] [Abstract][Full Text] [Related]
8. PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors.
Wang JJ; Burger P; Taube J; Soni A; Chaichana K; Sheu M; Belcaid Z; Jackson C; Lim M
Cureus; 2019 Dec; 11(12):e6352. PubMed ID: 31938638
[TBL] [Abstract][Full Text] [Related]
9. Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma.
Váraljai R; Horn S; Sucker A; Piercianek D; Schmitt V; Carpinteiro A; Becker KA; Reifenberger J; Roesch A; Felsberg J; Reifenberger G; Sure U; Schadendorf D; Helfrich I
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578810
[TBL] [Abstract][Full Text] [Related]
10. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
Front Immunol; 2020; 11():120. PubMed ID: 32117271
[TBL] [Abstract][Full Text] [Related]
11. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
[TBL] [Abstract][Full Text] [Related]
12. PLEKHA5 regulates tumor growth in metastatic melanoma.
Zhang H; Zhu H; Deng G; Zito CR; Oria VO; Rane CK; Zhang S; Weiss SA; Tran T; Adeniran A; Zhang F; Zhou J; Kluger Y; Bosenberg MW; Kluger HM; Jilaveanu LB
Cancer; 2020 Mar; 126(5):1016-1030. PubMed ID: 31769872
[TBL] [Abstract][Full Text] [Related]
13. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
14. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
[TBL] [Abstract][Full Text] [Related]
16. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.
Lee JH; Menzies AM; Carlino MS; McEvoy AC; Sandhu S; Weppler AM; Diefenbach RJ; Dawson SJ; Kefford RF; Millward MJ; Al-Ogaili Z; Tra T; Gray ES; Wong SQ; Scolyer RA; Long GV; Rizos H
Clin Cancer Res; 2020 Aug; 26(15):4064-4071. PubMed ID: 32321716
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation across the genome in aged human skeletal muscle tissue and muscle-derived cells: the role of HOX genes and physical activity.
Turner DC; Gorski PP; Maasar MF; Seaborne RA; Baumert P; Brown AD; Kitchen MO; Erskine RM; Dos-Remedios I; Voisin S; Eynon N; Sultanov RI; Borisov OV; Larin AK; Semenova EA; Popov DV; Generozov EV; Stewart CE; Drust B; Owens DJ; Ahmetov II; Sharples AP
Sci Rep; 2020 Sep; 10(1):15360. PubMed ID: 32958812
[TBL] [Abstract][Full Text] [Related]
19. The role of whole brain radiation therapy in the management of melanoma brain metastases.
Dyer MA; Arvold ND; Chen YH; Pinnell NE; Mitin T; Lee EQ; Hodi FS; Ibrahim N; Weiss SE; Kelly PJ; Floyd SR; Mahadevan A; Alexander BM
Radiat Oncol; 2014 Jun; 9():143. PubMed ID: 24954062
[TBL] [Abstract][Full Text] [Related]
20. Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Holbrook K; Lutzky J; Davies MA; Davis JM; Glitza IC; Amaria RN; Diab A; Patel SP; Amin A; Tawbi H
Cancer; 2020 Feb; 126(3):523-530. PubMed ID: 31658370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]